Skip to search formSkip to main contentSkip to account menu

Cardioplegin

Known as: Magnesate(2-), bis(L-aspartato(2-)-N,O1)-, (T-4)-, dihydrogen, mixt. with 2-(diethylamino)ethyl 4-aminobenzoate monohydrochloride 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (3)

Aspartic AcidProcaineSorbitol

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1991
1991
특집 : 1991 년도 추계 연수강좌 ; 호흡기질환 환자의 마취관리
Background: Verapamil, a calcium channel blocker, is known to protect the myocardium against ischemia and reperfusion injury. The… 
1981
1981
[Initial results of using Cardioplegin in heart operations].
1980
1980
Comparison of three methods of myocardial protection.
Ischemic arrest (45 minutes), injection cardioplegia (2-3 ml/kg body weight within 1 minute) using Cardioplegin (magnesium… 
1979
1979
Myocardial protection during heart surgery. An experimental evaluation of normothermic and hypothermic cardioplegia.
Heart surgery with hypothermic cardioplegia during normothermic bypass is sometimes complicated by rewarming of the myocardium… 
1979
1979
[Myocardial metabolic status in various methods of inducing a reversible heart arrest].
In experiments with dogs, three different methods of inducing a reversible cardiac arrest were compared: (A) the ischemic arrest… 
1978
1978
[Myocardial protection utilizing hypothermia and cardioplegin during surgical correction of congenital heart disease (author's transl)].
Our methods of myocardial protection are demonstrated in 846 patients subjected to open heart surgery for correction of… 
1978
1978
[Animal experiment evaluation of myocardial protection with a magnesium-asparaginate-procaine solution].
Cardioplegic myocardial protection with magnesium asparaginate procaine (Cardioplegin) is assessed in normothermic ischemia by… 
1975
1975
Induced ischemic cardiac arrest. Clinical and experimental results with magnesium-aspartate-procaine solution (Cardioplegin).
The risk of open heart surgery can be lowered by combination of different methods of myocardial protection. 1. Cardioplegia with… 
1975
1975
Herzmuskelelektrolyte bei der “kardioplegischen Myokardose”
SummaryChanges of the mineral concentrations of the heart muscle can point at disturbances of myocardial metabolism. Disturbances… 
1973
1973
[Usefulness of Cardioplegin in surgery with extracorporeal circulation].
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)